Dermapharm Holding SE (FRA:DMP) FFO


FRA:DMP Dermapharm Holding SE FRA:DMP
87 GF Score
Price €46.25
GF Value €39.11
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Dermapharm Holding SE FFO?

FFO (Funds from operations) only applies to REITs.

FRA:DMP
87GF Score
Dermapharm Holding SE FRA:DMP
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Dermapharm Holding SE (FRA:DMP) Overvalued in 2026?

Based on GuruFocus' analysis, Dermapharm Holding SE stock appears to be overvalued. The current stock price of €46.25 is trading 18.3% above its estimated GF Value™ of €39.11. GuruFocus considers Dermapharm Holding SE to be Modestly Overvalued.

Key valuation signals for FRA:DMP:

  • FFO:
  • GF Value™: €39.11 vs. price of €46.25 (18.3% above fair value)
  • GF Score™: 87/100 with 9 warning signs

No single metric tells the full story. See the FRA:DMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dermapharm Holding SE Business Description

Address Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031
Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.
87GF Score

Get the complete analysis for FRA:DMP

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€46.25
Price
€39.11
GF Value